Medical Developments International (FRA:M5D) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:M5D Medical Developments International Ltd FRA:M5D
46 GF Score
Price €0.26
GF Value €0.33
! 2 Warning Signs
View Full Analysis

What is Medical Developments International Net Loan?

Net Loan only applies to banks and insurance companies.

FRA:M5D
46GF Score
Medical Developments International Ltd FRA:M5D
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medical Developments International (FRA:M5D) Overvalued in 2026?

Based on GuruFocus' analysis, Medical Developments International stock appears to be undervalued. The current stock price of €0.26 is trading 21.8% below its estimated GF Value™ of €0.33.

Key valuation signals for FRA:M5D:

  • Net Loan:
  • GF Value™: €0.33 vs. price of €0.26 (21.8% below fair value)
  • GF Score™: 46/100 with 2 warning signs

No single metric tells the full story. See the FRA:M5D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medical Developments International Business Description

Other Exchanges MDDVF:USAMVP:Australia
Address 4 Caribbean Drive, Scoresby, VIC, AUS, 3179
Medical Developments International Ltd is a specialized healthcare company. The Company manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product, used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The segments of the company are Pain Management and Respiratory. The company derives maximum revenue from the Pain management segment.
46GF Score

Get the complete analysis for FRA:M5D

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.26
Price
€0.33
GF Value